8 February 2022 - For eight years, Beth Joyner Waldron has counted on Eliquis to treat clots in her lungs and legs.
In November 2021, she received a letter from CVS Caremark telling her the pharmacy benefit manager is excluding Eliquis from its formulary next year. Receiving the letter made her emotional.